| Helicos BioSciences Corporation announced in its third quarter Form 10-Q filing that, as previously disclosed, the company engaged Thomas Weisel Partners LLC, a nationally recognized investment bank, to assist the company with its evaluation and execution of strategic alternatives. Based on thecompany's improving standalone prospects and its current market valuation, the board has decided to disengage from discussions involving a potential sale of the company at the current time. The company continues to work with TWP as a financial advisor in connection with its long term financing strategy. :theflyonthewall.com |
